Contrary to the findings of previous studies, 800 mg/d of DHA delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to one trial.
Contrary to the findings of previous studies, 800 mg/d of docosahexaenoic acid (DHA) delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to a double-blind, randomized trial from Australia.
The study involved more than 2,000 women with singleton pregnancies of less than 21 weeks' gestation.
Researchers found that the percentage of women with high levels of depressive symptoms during the first 6 months postpartum did not differ between the group of women who took the DHA-filled capsules versus the group who took vegetable oil capsules without DHA (9.67% vs 11.19%; adjusted relative risk [RR], 0.85; 95% CI, 0.70-1.02; P=.09).
Makrides M, Gibson RA, McPhee AJ, et al; DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More